Cargando…
COPD exacerbations: defining their cause and prevention
Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflati...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134993/ https://www.ncbi.nlm.nih.gov/pubmed/17765528 http://dx.doi.org/10.1016/S0140-6736(07)61382-8 |
_version_ | 1783517954748448768 |
---|---|
author | Wedzicha, Jadwiga A Seemungal, Terence AR |
author_facet | Wedzicha, Jadwiga A Seemungal, Terence AR |
author_sort | Wedzicha, Jadwiga A |
collection | PubMed |
description | Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflation. They are triggered mainly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. Some patients are particularly susceptible to exacerbations, and show worse health status and faster disease progression than those who have infrequent exacerbations. Several pharmacological interventions are effective for the reduction of exacerbation frequency and severity in COPD such as inhaled steroids, long-acting bronchodilators, and their combinations. Non-pharmacological therapies such as pulmonary rehabilitation, self-management, and home ventilatory support are becoming increasingly important, but still need to be studied in controlled trials. The future of exacerbation prevention is in assessment of optimum combinations of pharmacological and non-pharmacological therapies that will result in improvement of health status, and reduction of hospital admission and mortality associated with COPD. |
format | Online Article Text |
id | pubmed-7134993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71349932020-04-08 COPD exacerbations: defining their cause and prevention Wedzicha, Jadwiga A Seemungal, Terence AR Lancet Review Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are associated with increased airway and systemic inflammation and physiological changes, especially the development of hyperinflation. They are triggered mainly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. Some patients are particularly susceptible to exacerbations, and show worse health status and faster disease progression than those who have infrequent exacerbations. Several pharmacological interventions are effective for the reduction of exacerbation frequency and severity in COPD such as inhaled steroids, long-acting bronchodilators, and their combinations. Non-pharmacological therapies such as pulmonary rehabilitation, self-management, and home ventilatory support are becoming increasingly important, but still need to be studied in controlled trials. The future of exacerbation prevention is in assessment of optimum combinations of pharmacological and non-pharmacological therapies that will result in improvement of health status, and reduction of hospital admission and mortality associated with COPD. Elsevier Ltd. 2007 2007-08-30 /pmc/articles/PMC7134993/ /pubmed/17765528 http://dx.doi.org/10.1016/S0140-6736(07)61382-8 Text en Copyright © 2007 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Wedzicha, Jadwiga A Seemungal, Terence AR COPD exacerbations: defining their cause and prevention |
title | COPD exacerbations: defining their cause and prevention |
title_full | COPD exacerbations: defining their cause and prevention |
title_fullStr | COPD exacerbations: defining their cause and prevention |
title_full_unstemmed | COPD exacerbations: defining their cause and prevention |
title_short | COPD exacerbations: defining their cause and prevention |
title_sort | copd exacerbations: defining their cause and prevention |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134993/ https://www.ncbi.nlm.nih.gov/pubmed/17765528 http://dx.doi.org/10.1016/S0140-6736(07)61382-8 |
work_keys_str_mv | AT wedzichajadwigaa copdexacerbationsdefiningtheircauseandprevention AT seemungalterencear copdexacerbationsdefiningtheircauseandprevention |